Cabaletta Bio, Inc. [CABA]

Source: 

Company Overview

Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of innovative engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases.